Anti-IGFBP3 antibody [EPR22152-22] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal IGFBP3 antibody. Carrier free. Suitable for WB, IP and reacts with Mouse, Rat samples. Cited in 1 publication.
View Alternative Names
Igfbp-3, Igfbp3, Insulin-like growth factor-binding protein 3, IBP-3, IGF-binding protein 3, IGFBP-3
- WB
Supplier Data
Western blot - Anti-IGFBP3 antibody [EPR22152-22] - BSA and Azide free (AB239789)
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure times.
Lane 1 : 8 seconds, Lane 2 : 81 seconds, Lane 3 : 3 minutes
IGFBP3 exists as both glycosylated (46 kDa) and non-glycosylated (29 kDa) form. The molecular weight observed is consistent with what has been described in the literature (PMID 10352394; PMID : 9698597; PMID 22910030).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab220429).
All lanes:
Western blot - Anti-IGFBP3 antibody [EPR22152-22] (<a href='/en-us/products/primary-antibodies/igfbp3-antibody-epr22152-22-ab220429'>ab220429</a>) at 1/1000 dilution
Lane 1:
Mouse lung primary cell culture supernatant at 20 µL
Lane 2:
Mouse serum at 20 µg
Lane 3:
Rat serum at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 32 kDa
Observed band size: 29 kDa,46 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-IGFBP3 antibody [EPR22152-22] - BSA and Azide free (AB239789)
IGFBP3 was immunoprecipitated from 0.35 mg of rat serum with ab220429 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab220429 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution.
Lane 1 : Rat serum 10 μg (Input).
Lane 2 : ab220429 IP in rat serum (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab20429 in rat serum.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
Both glycosylated (46 kDa) and non-glycosylated (29 kDa) IGFBP-3 are detected in rat serum. The molecular weight observed is consistent with what has been described in the literature (PMID 10352394; PMID : 9698597).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab220429).
All lanes:
Immunoprecipitation - Anti-IGFBP3 antibody [EPR22152-22] (<a href='/en-us/products/primary-antibodies/igfbp3-antibody-epr22152-22-ab220429'>ab220429</a>)
Predicted band size: 32 kDa
Observed band size: 29 kDa,46 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-IGFBP3 antibody [EPR22152-22] - BSA and Azide free (AB239789)
IGFBP3 was immunoprecipitated from 0.35 mg of mouse serum with ab220429 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab220429 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.
Lane 1 : Mouse serum 10 μg (Input).
Lane 2 : ab220429 IP in mouse serum (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab20429 in mouse serum.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
Non-glycosylated IGFBP-3 (29 kDa) is detected in mouse serum. The molecular weight observed is consistent with what has been described in the literature (PMID 10352394).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab220429).
All lanes:
Immunoprecipitation - Anti-IGFBP3 antibody [EPR22152-22] (<a href='/en-us/products/primary-antibodies/igfbp3-antibody-epr22152-22-ab220429'>ab220429</a>)
Predicted band size: 32 kDa
Observed band size: 29 kDa
false
Reactivity data
Product details
ab239789 is the carrier-free version of ab220429.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in medicine 12:1614012 PubMed40959429
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com